Position in RXRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,766,410
+$1,602,091 QoQ
Shares Held
901,111
+277.7% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GROUP ONE TRADING LLC holds $126,618,308 across 210 Biotechnology names. RXRX ranks #15 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
363,997 | $23,991,042 | |
| 2 | BNTX |
BioNTech SE
|
103,948 | $9,238,898 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
211,817 | $6,892,525 | |
| 4 | AGIO |
Agios Pharmaceuticals, Inc.
|
173,279 | $5,862,028 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
96,001 | $4,566,767 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,357 | $4,178,274 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,399 | $4,171,483 | |
| 8 | ABVX |
Abivax S.A.
|
35,767 | $3,982,655 |
All Filings in RXRX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,766,410 | 901,111 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | $1,164,319 | 238,590 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $439,476 | 86,853 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,901,575 | 359,466 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,904,319 | 281,704 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $1,253,253 | 190,175 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $936,307 | 124,841 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $47,651 | 6,229 | Shares | Sole | 2023-11-09 | |
| 2022-12-31 | $42,181 | 5,471 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $73,416 | 6,900 | Shares | Sole | 2022-11-09 | |
| No filing history on record for this holder in this stock. | ||||||